FDA Panel Puts Spironolactone in Play for HF With Preserved EF FDA Panel Puts Spironolactone in Play for HF With Preserved EF

Most FDA advisers agreed data from TOPCAT were flawed but could support a new indication for the decades-old generic drug.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news